The effect of urinary incontinence on health utility and health-related quality of life in men following prostate surgery§


  • Brian S. Buckley,

    Corresponding author
    1. Department of General Practice, National University of Ireland, Galway, Ireland
    2. Bladder and Bowel Foundation, SATRA Innovation Park, Kettering, England
    • Department of Surgery, College of Medicine, Philippine General Hospital, Taft Avenue, Manila, Philippines.
    Search for more papers by this author
  • M.C.M. Lapitan,

    1. Division of Urology, Department of Surgery, College of Medicine, Philippine General Hospital, Manila, and National Institutes of Health, University of the Philippines—Manila, Philippines
    Search for more papers by this author
  • C.M. Glazener,

    1. Health Services Research Unit, University of Aberdeen, Foresterhill, Aberdeen, Scotland
    Search for more papers by this author
  • for the MAPS Trial Group

  • Eric Rovner led the review process.

  • Conflict of interest: none.

  • §

    Trial Registration: The MAPS Study was registered with the International Standard Randomised Controlled Trial Number Register, ISRCTN87696430 (



The impact of urinary incontinence (UI) on health-related quality of life (HRQoL) has been less well researched in men than women and the general population. This study aims to assess the association between UI and HRQoL in men 1 year after prostate surgery.


Planned secondary analysis of data from two parallel randomized controlled trials of active conservative treatment for UI in 853 men following radical prostatectomy (RP) and transurethral resection of the prostate (TURP). Men of any age were eligible for trial inclusion if they were experiencing UI 6 weeks after undergoing RP or TURP at 34 centers in the United Kingdom. Univariate and multivariate analysis considered associations between health status (SF-12 and EQ-5D) and self-reported UI. Multivariate analysis controlled for age, obesity, UI prior to surgery, and concomitant fecal incontinence.


Mean age of 411 men in the RP trial was 62.3 years (SD 5.7) and 442 men in the TURP trial was 68.0 (SD 7.9). Of men with UI at 6 weeks after surgery, 76.7% in the RP group and 63.2% in the TURP group still had UI at 12 months. Any UI at 12 months was significantly associated with reduced HRQoL in the RP group and lower EQ-5D and SF-12 Mental Component Scores in the TURP group.


Any UI is a significant factor in reduced HRQoL in men following prostate surgery, particularly younger men who undergo RP. Its importance to patients as an adverse outcome should not be underestimated. Neurourol. Urodynam. 31:465–469, 2012. © 2012 Wiley Periodicals, Inc.